4Freeman ML, Disario JA, Nelson DB, et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc, 2001,54 ( 4 ) : 425 - 434.
5Friedland S, Soetikno RM, Vandervoort J, et al. Bedside scoring system to predict the risk of developing pancreatitis following ERCP. Endoscopy,2002,34(6) :483 - 488.
6Mehta SN, Pavone E, Barkun JS, et al. Predictors of post-ERCP complications in patient with suspected choledocholithiasis. Endoscopy, 1998,30 (5) :457 - 463.
7Kaw M, Singh S. Serum lipase,C-reactive protein and interleukin-6 levels in ERCP-induced pancreatitis. Gastrointest Endosc, 2001,54 ( 4 ) : 435 - 440.
8Oezcueruemez-Porsch M, Kunz D, Hardt PD, et al. Diagnostic relevance of interleukin pattem, acute-phase proteins, and procalcitonin in early phase of post-ERCP pancreatitis. Dig Dis Sci, 1998,43(8) : 1763 - 1769.
9Raty S, Sand J, Laine S, et al. Cholecystokinin in the early course of acute post-ERCP pancreatitis. J Am Coil Surg, 1999,189 (6) :560 - 565.
10Baillie J. Increased serum trypsinogen 2 and trypsin 2-1 antitrypsin complex values identify endoscopic retrograde cholangiopancreatography (ERCP)-induced pancreatitis with high accuracy.Gastrointest Endosc, 1998,47(6) :554 - 556.
8Mesta SN, Pavone E, Barkun JS, et al. Predictors of post-ERCP complications in patient with suspected eholedocholithiasis[J]. Endoscopy,1998,30(5) :457 -463.
9Poon RT,Fan ST. Antisecretory agents prevention of post-ERCP pancreatitis :rationale for use and clinical results [ J ]. JOP,2003,4 (1) : 33.
10Besselink MG, vanMinnen LP, vanErpecum KJ, et al. Beneficial effects of ERCP and papillotomy in predicted severe biliary pancreatitis[ J ]. Hepatogastroenterology ,2005,52 (61) :37 - 39.
